Edit |   |
---|---|
Antigenic Specificity | IFNG, Human (Fontolizumab biosimilar) |
Clone | Fontolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IFNG Recombinant Antibody (Fontolizumab). Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint. |
Immunogen | n/a |
Other Names | Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab, Anti-Human IFNG Recombinant Antibody(Fontolizumab), HuZAF, Antibody Drug Analogues, Monoclonal Antibody, YR1022, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 326859-36-3 |
Catalog # | YR1022 |
Price | please inquire |
Order / More Info | IFNG, Human (Fontolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |